Description
Composition: Each tablet contains:
-
Linagliptin 5 mg
-
Dapagliflozin 10 mg
Dosage Form: Tablet
Route of Administration: Oral
Drug Class:
-
Linagliptin – DPP-4 (Dipeptidyl Peptidase-4) Inhibitor
-
Dapagliflozin – SGLT2 (Sodium-Glucose Co-Transporter-2) Inhibitor
Therapeutic Use: Used for the management of type 2 diabetes mellitus to improve glycemic control, as an adjunct to diet and exercise, either alone or in combination with other antidiabetic agents.
Reviews
There are no reviews yet.